It is bizarre the study was out of China and was temporarily posted on the WHO’s website.
Amazing how drugs don't do so well when subjected to a proper trial.
First rule of medicine: there’s never a silver bullet
That said, I personally know doctors here in the Bay Area who were part of the remedsivir trial and it does seem to genuinely help in very specific cases.
2 out of 3 candidates fail in Phase II. We wish we could predict which ones succeed, and still we can't. It's a complete mystery.
this is from an RCT. This data is way more powerful than compassionate use data, those are so noisy that are almost impossible to see any signal.